North China Pharmaceutical Company.Ltd

XSSC:600812 Stock Report

Market Cap: CN¥10.3b

North China Pharmaceutical Company.Ltd Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Li Xin Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.1yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2.6yrs

Recent management updates

Recent updates

CEO

Li Xin Wang (52 yo)

1.1yrs

Tenure

CN¥706,900

Compensation

Mr. Li Xin Wang serves as Chairman of the Board of Directors and General Manager at North China Pharmaceutical Company Ltd from April 23, 2024. He served as the Chief Accountant and Chief Financial Officer...

Board Members

NamePositionTenureCompensationOwnership
Li Xin Wang
Chairman of the Board of Directors & GM1.1yrsCN¥706.90kno data
Guangcheng Pan
Independent Director6yrsCN¥71.40kno data
Yao Cao
Director6.7yrsCN¥200.40kno data
Fan Li
Supervisor6.7yrsno datano data
Jigang Xie
Independent Director4.1yrsCN¥71.40kno data
Demin Zhou
Independent Director6yrsCN¥71.40kno data
Yalou Wang
Director2.6yrsno datano data
Xiujun Wang
Director2.6yrsno datano data
Rentao Song
Director2.2yrsno datano data
Wei Lv
Chairman of the Supervisory Board2.6yrsno datano data
Zhenguo Chai
Independent Director2.6yrsno datano data
Wenzan Gao
Supervisor2.6yrsno datano data

2.6yrs

Average Tenure

53.5yo

Average Age

Experienced Board: 600812's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 18:56
End of Day Share Price 2025/05/19 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

North China Pharmaceutical Company.Ltd is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hongbao ZhangChina Merchants Securities Co. Ltd.
Kai WangCitic Securities Co., Ltd.
null Research DepartmentGuotai Junan International Holdings Limited